Partner Content Partner Content Overwhelmed with KOL Data how to navigate through KOL insights & management
Partner Content Partner Content Summarising & Combining Insights Highlight, prioritize & combine your MSL insights
Views & Analysis Improving oncology KOL engagement Combining technology with human insights is a powerful tool in identifying and engaging effectively with oncology experts.
News GSK pursues $10.6bn takeover of cancer biotech Nuvalent GSK is preparing for its biggest acquisition in more than 10 years, agreeing to buy cancer drug developer Nuvalent for $10.6 billion.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
